AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05591664 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: eicosapentaenoic acid
Description: eicosapentaenoic acid levels of the groups will be monitored
Study NCT04147104 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low flow ECCO2R
Description: Treatment with a medical device called ECCO2R. The device consists of a drainage cannula placed in a large central vein, a membrane lung (artificial gas exchanger), and a return cannula into the venous system. Blood is pumped through the membrane lung, and CO2 is removed by diffusion. A flowing gas known as sweep gas containing little or no CO2 runs along the other side of the membrane, ensuring a diffusion gradient from blood to the other side, hence promoting CO2 removal.
Study NCT04147104 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation
Description: Invasive mechanical ventilation deviceto support acute respiratory failure and facilitate exhalation via an endotracheal tube or tracheotomy.
Study NCT04147104 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Invasive mechanical ventilation
Description: Invasive mechanical ventilation deviceto support acute respiratory failure and facilitate exhalation via an endotracheal tube or tracheotomy.
Study NCT06534450 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: The patient's blood will not circulate through the apheresis machine. The patient will receive approximately 250 cc of normal saline during each sham pheresis procedure.
Study NCT06534450 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic Plasma Exchange
Description: Blood is withdrawn from a peripheral or central vein into the blood cell separator which separates the whole blood into plasma and cell components. The plasma is removed and the blood cells are returned to the patient along with replacement fluids, most commonly 5% human albumin in normal saline.
Study NCT06534450 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IVIG
Description: Intravenous Immunoglobulin
Study NCT04753827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Drug eluting stent
Description: Put a Drug eluting stent in the blood vessel
Study NCT04753827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Durg coated balloon
Description: Put a Durg coated balloon in the blood vessel
Study NCT05361772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: colchicine
Description: colchicine 0.5mg per day for 24 months
Study NCT05361772 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo 0.5mg per day for 24 months
Study NCT06519019 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental Implant Surgery - Hydrophilic group
Description: A full thickness mucoperiosteal flap was elevated, under Local anaesthesia, osteotomy sites were prepared according to manufactures instructions, and parallel pin was used to confirm position and angulation of osteotomy site. One site received a hydrophilic implant and the other site received a conventional implant.~Ostell ISQ was used to measure primary stability of the dental implant. The surgical wound closure was with mattress and single interrupted sutures, using 4-0 vicryl suture.
Study NCT06519019 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental Implant Surgery - Conventional group
Description: A full thickness mucoperiosteal flap was elevated, under Local anaesthesia, osteotomy sites were prepared according to manufactures instructions, and parallel pin was used to confirm position and angulation of osteotomy site. One site received a hydrophilic implant and the other site received a conventional implant.~Ostell ISQ was used to measure primary stability of the dental implant. The surgical wound closure was with mattress and single interrupted sutures, using 4-0 vicryl suture.
Study NCT06440512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dark chocolate Intervention
Description: The intervention involves daily consumption of 50 grams of dark chocolate for a period of two weeks. The dark chocolate is provided in tablet form, and participants are instructed to consume it daily.
Study NCT06440512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White chocolate Intervention
Description: The intervention involves daily consumption of 40 grams of white chocolate for a period of two weeks. The dark chocolate is provided in tablet form, and participants are instructed to consume it daily.
Study NCT06407180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triamcinolone Acetonide
Description: receive intraarticular triamcinolone injection
Study NCT06407180 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: receive intraarticular normal saline injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: administered via Intravenous (IV) injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin injection
Description: administered via IV injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin injection
Description: administered via IV injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin injection
Description: administered via IV injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin injection
Description: administered via IV injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide injection
Description: administered via IV injection
Study NCT06375109 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoposide injection
Description: administered via IV injection
Study NCT04762537 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Induction Procedure (SP)
Description: SP includes stabilization on buprenorphine (6-8 mg) on Day 1 followed by a taper over the subsequent 4 days. After the completion of buprenorphine taper, participants will enter a washout period of at least 8 days. On the last day of the washout period, participants will be evaluated for eligibility to receive XR-NTX injection. Once found eligible, an XR-NTX injection will be given.
Study NCT04762537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapid Induction Procedure (RP)
Description: RP includes 1 day of buprenorphine 6-8 mg, followed by a day of washout and 4 days of oral naltrexone titration. If the participant is able to tolerate the last dose of the naltrexone titration, an XR-NTX injection will be given
Study NCT05461612 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spatial Resynchronization Therapy delivered by the MAX-SRS, external recording and stimulation device
Description: Delivery of algorithmically defined pacing stimuli over a multitude of electrodes placed on the left atrium.
Study NCT05772260 — intervention group
Intervention type: PROCEDURE
Intervention: Per-oral endoscopic myotomy
Description: Per-oral endoscopic myotomy will be performed under general anesthesia. Per-oral endoscopic myotomy will be performed according to the standard care.~General anesthesia will be conducted according to the standard care in our institution, and standardized as follows.~* Monitoring: ECG, SpO2, noninvasive blood pressure, invasive blood pressure monitoring via radial artery cannulation, advanced hemodynamic monitoring (including cardiac output, cardiac index) uisng EV1000 clinical platform (Edwards Lifesciences, USA), anesthetic depth monitoring by SedLine Sedation monitor (Masimo corporation).~* Anesthetic induction: Target controlled infusion (TCI) of Remifentanil (target 3.0 ng/mL), propofol 2 mg/kg IV, rocuronium 0.8 mg/kg IV~* Anesthetic maintence: sevoflurane 0.9 age corrected MAC and remifentanil TCI (target range 1.0-4.0 ng/mL)
Study NCT06223282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: short inter-set rest resistance exercise
Description: Subjects in short inter-set rest trial performed 3 sets per exercise, 7 repetitions with load of 70%-1RM with 60 sec of rest between sets.
Study NCT06223282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: medium inter-set rest
Description: Subjects in medium inter-set rest trial performed 3 sets per exercise, 7 repetitions with load of 70%-1RM with 120 sec of rest between sets.
Study NCT06223282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: long inter-set rest
Description: Subjects in long inter-set rest trial performed 3 sets per exercise, 7 repetitions with load of 70%-1RM with 180 sec of rest between sets.
Study NCT06223282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: medium inter-set rest with failure
Description: Subjects in long inter-set rest trial performed 3 sets per exercise, repeated to failure with load of 70%-1RM with 120 sec of rest between sets.
Study NCT05110053 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Cord Stimulator
Description: Spinal Cord stimulation is a recognized treatment of chronic neuropathic pain. The procedure of implantation is the same in this study. Surgery is done in local anaesthesia. A small electrode is placed in the epidural space corresponding approximately at the Th8-Th10 level.~An impulsegenerator, connected to the electrode, is placed in the subcutaneus fat in the gluteal region.
Study NCT05110053 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Spinal Cord Stimulator
Description: Spinal Cord stimulation is a recognized treatment of chronic neuropathic pain. The procedure of implantation is the same in this study. Surgery is done in local anaesthesia. A small electrode is placed in the epidural space corresponding approximately at the Th8-Th10 level.~An impulsegenerator, connected to the electrode, is placed in the subcutaneus fat in the gluteal region.
Study NCT04704232 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ACD440
Description: Double blind, parallel within subject comparison
Study NCT04704232 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PLAC
Description: Double blind, parallel within subject comparison
Study NCT05482230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Changes in intubation position
Description: The change of intubation mode is accomplished in lateral position
Study NCT04595903 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemopurifier
Description: Hemopurifier treatments will be one four to six hour treatment session daily for up to 4 days
Study NCT05874973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time-controlled adaptative ventilation (TCAV)
Description: Ventilation with TCAV set on the APRV mode on the ventilator.
Study NCT05874973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Description: Ventilation with the VCV mode set on the ventilator.
Study NCT05651295 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Checking the Facts
Description: Checking the Facts is a form of cognitive reappraisal in which participants identify negatively-valenced automatic thoughts and both generate and consider evidence that challenges the validity of those thoughts.
Study NCT05651295 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Opposite to Emotion Action
Description: Opposite to Emotion Action teaches participants to identify their momentary emotion(s), identify the associated behavioral urge(s), and implement a behavior inconsistent with that urge (e.g., approaching a feared stimulus instead of avoiding it).
Study NCT05651295 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness of Current Emotions
Description: Mindfulness of Current Emotions teaches participants to nonjudgmentally observe the experience of their emotions, including physiological and cognitive responses to those emotions.
Study NCT05999188 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: No interventions will be given to patients.
Study NCT04248413 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction Therapy
Description: The blood flow restriction cuff, which is regulated by the FDA under 878.5910 and is registered under number 9681444, is manufactured by Delfi Medical. The cuff will be used as recommended by the manufacturer and Owens Recovery Science, the company who provides certificating of blood flow restriction training.
Study NCT04248413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard physical rehabilitation
Description: Patients diagnosed with non-operative rotator cuff or biceps tendinopathy will undergo physical rehabilitation under the supervision of the same physical therapists who will be performing the BFR therapy.
Study NCT04248413 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard physical rehabilitation
Description: Patients diagnosed with non-operative rotator cuff or biceps tendinopathy will undergo physical rehabilitation under the supervision of the same physical therapists who will be performing the BFR therapy.
Study NCT04788654 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celebrex, acetaminophen, and dexamethasone
Description: Pharmacological intervention will be performed. Celebrex 200mg, acetaminophen 1g, and dexamethasone 7 mg will be infused perioperatively.
Study NCT04788654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celebrex, acetaminophen, and dexamethasone
Description: Pharmacological intervention will be performed. Celebrex 200mg, acetaminophen 1g, and dexamethasone 7 mg will be infused perioperatively.
Study NCT04788654 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Saline irrigation, aspiration of pneumoperitoneum, and low pressure penumoperitoneum
Description: Surgical intervention will be performed. Saline irrigation, aspiration of pneumoperitoneum, and low pressure pneumoperitoneum will be performed.
Study NCT05743452 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GBR with CS@Mg
Description: The patient was treated by GBR with magnesium calcium silicate scaffold for alveolar bone defect.
Study NCT05802719 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sampling
Description: The procedure consists of collecting 4 additional tubes of blood (20mL) at each visit for research purposes, in order to perform the immunological assays.~Blood samples at the inclusion, 3 month and 6 month after initiation of anti-TNF therapy
Study NCT05878223 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal shock waves
Description: Both group received extracorporeal shock waves therapy
Study NCT05878223 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock waves
Description: Both group received extracorporeal shock waves therapy
Study NCT05418777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trimethoprim Sulfamethoxazole
Description: Receipt of suspension with the equivalent of one DS TMP-SMX by mouth every 12 hours for 10 days
Study NCT05418777 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Receipt of suspension with placebo by mouth every 12 hours for 10 days
Study NCT04933565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ORG-129
Description: ORG-129 oral capsules
Study NCT04933565 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral capsules
Study NCT02194751 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Oncoquest-L vaccine
Description: Patients will receive a total of 5 single administrations of Oncoquest-L; the first 2 doses administered will be separated by a 2-week interval and the remaining 3 doses will be administered each at 1-month intervals. With each dose of Oncoquest-L vaccine, the vaccine will be administered subcutaneously at 2 different sites in the upper arms or upper legs, with alternation of the injection sites with each administration. For each vaccination, a total of 1.0 mL of vaccine will be administered, divided into 2 subcutaneous injections of 0.5 mL each at 2 different injection sites.
Study NCT05870267 — intervention group
Intervention type: DEVICE
Intervention: Power Knee with bone anchored suspension
Description: Motor powered microprocessor controlled prosthetic knee joint
Study NCT05870267 — intervention group
Intervention type: DEVICE
Intervention: C-Leg
Description: Passive hydraulic microprocessor controlled prosthetic knee joint
Study NCT06208722 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism
Description: Information provided in arm descriptions.
Study NCT06208722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism
Description: Information provided in arm descriptions.
Study NCT06043596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SafeSpace Sexual Health
Description: The overall goal of the program is to prevent adolescent pregnancy and STIs by increasing sexual agency, increasing the use of condoms and contraception, and promoting healthy relationships and healthy life skills among adolescents.
Study NCT06043596 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SafeSpace General Health
Description: This arm represents the comparison group. SafeSpace General Health will act as the active comparator, while providing youth with lessons, facts, and resources about general health topics.
Study NCT05870267 — intervention group
Intervention type: DEVICE
Intervention: Rheo Knee XC
Description: Passive magneto-rheologic microprocessor controlled knee joint
Study NCT05630079 — intervention group
Intervention type: DEVICE
Intervention: Treatment with Metaneb®
Description: Every patient of this group receive 3 daily treatments of 20 minutes each, performed at approximately 4-hour intervals.~Each treatment with MetaNeb system consists of four cycles: : 5 minutes of Continuous Positive Expiratory Pressure (CPEP) for lung re-expansion (Cycle I), 5 minutes of Chest High Frequency Oscillation (CHFO) for secretion clearance (Cycle II), 5 min of CPEP (Cycle III), 5 minutes of CHFO (Cycle IV). Treatments are performed by respiratory physiotherapists and the pressure setted was the highest tolerated by the patient. It's associated with the administration of aerosols with 10 ml of saline solution 0.9% and are carried out by connecting the tracheostomy cannula cuffed to the catheter mount.
Study NCT05630079 — intervention group
Intervention type: DEVICE
Intervention: Treatment with IPV®
Description: Each treatment with IPV provides 3 daily treatments of 20 minutes with the high percussion frequency tolerated by the patient. and I/E ratio: 1/1.2. Treatments are performed by respiratory physiotherapists and the pressure setted was the highest tolerated by the patient. It is associated with the administration of aerosols with 10 ml of saline solution 0.9% \[-\] and are carried out by connecting the tracheostomy cannula cuffed to the catheter mount.
Study NCT05461911 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Nutrison Advanced Cubison
Description: (20% protein energy 100 kcal, 5.5 g protein, 0.85 g arginine, 38 mg of vitamin C and 2 mg of zinc) in a volume not exceeding 1.5 liters / day and, if necessary, to replenish nutritional needs based on the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g of protein / kg body weight / day according to the recommendations for nutritional support
Study NCT04670926 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: TruGraf
Description: TruGraf results will be available in real-time and used by the physician in conjunction with other standard of care labs to guide management of immunosuppression as follows:~Patients with a stable serum creatinine and eGFR of > 45 mL/min who also have a TruGraf TX result at month 3 will have their Mycophenolate Mofetil or Mycophenolate Sodium decreased from a standard dose of 1000 mg twice daily to 500 mg twice daily or 720 mg twice daily to 360 mg twice daily respectively.~Patients with a stable serum creatinine and estimated eGFR of > 45 mL/min who also have a TruGraf TX result at months 4, 5, and 6 will have their Tacrolimus target trough level decreased to a target between 3 and 6.~Patients with TruGraf not-TX will have no further immunosuppression reduction and continued to be monitored.
Study NCT05279547 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Constant-load bed-cycling exercise
Description: Patients will actively cycle for a minimum duration of 10 minutes and a maximum duration of 20 minutes without breaks.
Study NCT05279547 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interval bed-cycling exercise
Description: Patients will cycle for the same duration as during constant-load exercise. Interval bed-cycling session will consist of 30 seconds of high intensity exercise alternated by 30 seconds of passive cycling designed so that volume of training will be equal.
Study NCT04955756 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: mNGS
Description: Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment.
Study NCT05733871 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: meal replacement product- STANDARD PRODUCT
Description: standard product line contains common ingredients and this type of product already exists on world markets
Study NCT05733871 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Meal replacement product- INNOVATIVE PRODUCT
Description: innovative product line contains raw materials that are considered better sources of potentially bioactive components
Study NCT05218785 — intervention group
Intervention type: DRUG
Intervention: Botox
Description: 75 U in medial gastrocbemius head. x 3
Study NCT04820894 — intervention group
Intervention type: OTHER
Intervention: Electronic Medical Record
Description: Medical records are reviewed
Study NCT04820894 — intervention group
Intervention type: OTHER
Intervention: Survey Administration
Description: Complete surveys